Omaha Councilor Brinker Harding’s Dual Role in Big Pharma Debate
Brinker Harding, a Republican and Omaha city councilor, is making headlines as he runs for Congress in Nebraska’s 2nd District. Harding, who is up against Democratic candidate and small business owner Denise Powell, has publicly committed to tackling the challenges posed by Big Pharma.
In a video shared on social media on August 4, Harding emphasized the importance of affordable healthcare for Nebraskans. He voiced his support for a most-favored nation policy aimed at reducing drug costs, a measure initially promoted by former President Donald Trump.
The proposed policy seeks to align Medicaid drug payments with the amounts paid by other countries, a move the White House believes could save billions for the federal government. However, critics argue that such measures might not effectively diminish the pharmaceutical industry’s influence on drug pricing, nor ensure reduced medication costs for consumers.
Harding had previously expressed his support for this approach in a January op-ed for the Omaha World-Herald, where he criticized the practice of providing taxpayer-funded bailouts to large pharmaceutical and insurance companies.
Despite his stance, financial disclosures reveal that Harding and his spouse have investments totaling up to $125,000 in Pfizer and AbbVie, two major players in the pharmaceutical industry. Both companies have faced legal challenges for price inflation and profiteering allegations.
Although Pfizer and AbbVie agreed to a voluntary most-favored nation pricing deal with the Trump administration last year, they proceeded to increase drug prices in 2026.
Healthcare affordability is a key topic in the current election cycle. Denise Powell’s campaign focuses on imposing a $35 monthly cap on insulin costs for all Americans, highlighting the ongoing debate over drug pricing and access to affordable healthcare.
The post Brinker Harding has up to $125,000 invested in Big Pharma appeared first on American Journal News.
—
Read More Kitchen Table News
